TrialAdvances in therapy2021

Quality of Life and Work Productivity Improvements with Upadacitinib: Phase 2b Evidence from Patients with Moderate to Severe Crohn's Disease.

Laurent Peyrin-Biroulet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.